SEATTLE--(BUSINESS WIRE)-- #ContraceptiveDrugDeliveryDevices--North America region is expected to hold a dominant position in the global implantable drug delivery devices market over the forecast 2020-2027.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced that the first patient has been dosed in a multicenter Phase 1 clinical trial of JSP191, a first-in-class humanized monoclonal antibody. The trial is evaluating JSP191 as a conditioning agent in patients with two types of hematologic disorders – myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) – who are undergoing blood or
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, October 27, 2020. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Third Quarter 2020 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Info
BOSTON & SEATTLE--(BUSINESS WIRE)--Thomas H. Lee Partners, L.P. (“THL”) and Frazier Healthcare Partners (“Frazier”) today announced they have acquired Adare Pharmaceuticals, which will be rebranded Adare Pharma Solutions (“Adare”), a leading specialty contract development and manufacturing organization (CDMO) and global provider of advanced pharmaceutical technologies, from TPG Capital. The acquisition includes Adare’s CDMO, pharmaceutical technology and microbiome businesses, while TPG Capital
SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--TPG Capital, the private equity platform of alternative asset firm TPG, announced today that it has formed a new specialty pharmaceutical company called Ellodi Pharmaceuticals. Ellodi Pharmaceuticals is dedicated to the clinical development of APT-1011, a novel therapy in Phase 3 development for the treatment of Eosinophilic Esophagitis (EoE) spun-out of Adare Pharmaceuticals (Adare). The formation of Ellodi Pharmaceuticals follows TPG Capital
MINNEAPOLIS--(BUSINESS WIRE)--Reemo Health Receives Provider Approval, Giving More Users Access to Personal Independence Smartwatch.
SEATTLE--(BUSINESS WIRE)-- #EnzymeReplacementTherapy--North America is expected to hold a dominant position in the global mucopolysaccharidosis (MPS) treatment market over the forecast 2020-2027.
NEW HAVEN, Conn.--(BUSINESS WIRE)--Yale OB/GYN Mary Jane Minkin, shares insights on the emotional and physical impacts of a breast cancer diagnosis on sexuality and intimacy.
RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS--Marinus Pharmaceuticals announced that it will effect a one-for-four reverse stock split of its common stock at 5:00 pm ET today.
NEW YORK--(BUSINESS WIRE)-- #IoT--Medigate, the leader in IoT and medical device security and asset management, today announced that it has entered into an agreement with Arrow Electronics, Inc. to bring healthcare delivery organizations (HDOs) award-winning cybersecurity solutions for their connected devices. The agreement will help HDOs in securing the right powerful cybersecurity threat protection solution for their clinical networks. “The healthcare industry is under attack, with the frequency of
LOS ALTOS, Calif.--(BUSINESS WIRE)-- #AI--Cerebras Systems Expands Global Footprint with New Offices in Tokyo, Japan, and Toronto, Canada
NEW YORK--(BUSINESS WIRE)--Genosity, Inc., an innovative biotechnology company that provides comprehensive software and technical solutions to enable precision medicine announced today that it has entered into a strategic collaboration with Personal Genome Diagnostics Inc. (PGDx), one of the leading companies in cancer genomics, that recently received market clearance from the U.S. Food and Drug Administration (FDA) for PGDx elio™ tissue complete, a comprehensive diagnostic kit for genomic prof
COOKEVILLE, Tenn.--(BUSINESS WIRE)-- #contractpharma--Aphena begins game-changing $21 million expansion, including capacity for biologics and cold chain storage, of its Solid Dose Division in Tennessee.
SPRINGFIELD, Ill.--(BUSINESS WIRE)-- #ADAP--Illinois HIV Care Connect Encourages Social Media Conversations in “Speaking Up About HIV Stigma” Campaign.
MADISON, Wis.--(BUSINESS WIRE)--Promega will develop its OncoMate™ MSI Assay as a companion diagnostic test for Incyte’s anti-PD-1 drug candidate in endometrial cancer.
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aural Analytics, Inc., an industry leading speech neuroscience and speech analytics technology company, announced today it has launched A2ETM, a mobile application SDK and Web API designed to make speech collection and cloud-based analytics ubiquitous across clinical research, in any health application, and for in-clinic and remote settings. As the healthcare community continues to recognize the power of speech analysis for use in the identification and track
NEW YORK--(BUSINESS WIRE)--PURPLESUN form a private sector partnership to provide FMUV Shadowless Deliver light decontamination technology to Government Agencies.
WASHINGTON--(BUSINESS WIRE)--The Physicians Committee for Responsible Medicine filed a lawsuit on Sept. 22 against the Food and Drug Administration (FDA) for failing to respond to a petition that asks the agency to require cheese manufacturers to add the following warning label on all dairy cheese products: “Dairy cheese contains reproductive hormones that may increase breast cancer mortality risk.” The petition, which was filed on Oct. 3, 2019, cites several studies linking consumption of chee
MIAMI--(BUSINESS WIRE)--PreCheck partners with KEO World to provide medical equipment financing for its PC8B medical device
SAN DIEGO--(BUSINESS WIRE)--Dexcom G6 Continuous Glucose Monitoring System Now Available at Veterans Affairs Pharmacies Across the United States
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Answers Is Named a J.D. Power 2020 Certified Customer Service Program
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has partnered with a large pharmaceutical company to validate the AIDD Module in ADMET Predictor 10.0 (APX).
WALTHAM, Mass.--(BUSINESS WIRE)--Genetics Research non-exclusively licenses proprietary targeted DNA enrichment technologies to Oxford Nanopore Technologies.
CINCINNATI--(BUSINESS WIRE)--Eikonoklastes Therapeutics names Tom Finn, retired president, P&G Global Personal Health Care, former president, P&G Pharmaceuticals, to its Board.
LAWRENCE, Mass.--(BUSINESS WIRE)--obp, the leading global developer of single-use, self-contained, illuminating medical devices, today announced the launch of ONETRAC LXD, a single-use, cordless dual-blade surgical retractor with integrated multi-LED light source and dual smoke evacuation channels and ONETRAC LXS, a single-use suction device with integrated, cordless radial LED light source. ONETRAC LXD’s innovative patent-pending dual-blade LED circuitry enables instantaneous transition betwee
BREA, Calif.--(BUSINESS WIRE)-- #HealthKiosk--ViewSonic Introduces Health Flex Hand-Sanitizing Stations with Integrated Display and Media Player Options
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ohana Biosciences, a pioneering reproductive health company that created the world’s first sperm biology platform for sperm-based products, today announced it has completed patient enrollment in its SPRING study (SPeRtility, IVF Next Generation) of Spertility™. Spertility is a sperm cell treatment designed to improve outcomes for people using Assisted Reproductive Technology (ART), such as In-Vitro Fertilization (IVF). “Completing enrollment in our initial cli
WALTHAM, Mass.--(BUSINESS WIRE)-- #autism--Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical Science
SUNNYVALE, Calif.--(BUSINESS WIRE)-- #LinkedInTopStartups--LinkedIn releases its annual Top Startups list, ranking the top 50 emerging and growing startups in the U.S.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) announced this week at Biotech Week Boston the establishment of Immerse™ Cambridge, a new Waters' research laboratory in the heart of Cambridge’s Kendall Square. Immerse Cambridge will serve as a strategic, collaborative space in the community, where Waters can partner with academia, research and industry to accelerate the next generation of scientific advancements. “Immerse Cambridge will house the latest analytical instruments a
PHOENIX--(BUSINESS WIRE)--TransMed7, LLC announced today that the first of the vacuum-assisted, Single Insertion - Multiple Collection (SIMC™) breast biopsy procedures utilizing its SpeedBird 38 soft tissue biopsy device was successfully performed by Dr. Richard Fine, a distinguished surgeon and former Chairman and President of the American Society of Breast Surgeons (ASBrS). TransMed7 anticipates participating in the next ASBrS meeting to be held in Orlando, Florida, where it will report the c
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it has recently commenced phase III clinical trials for its inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences (Sinovac LS), or “CoronaVac,” in Turkey. The phase III clinical trial seeks to test efficacy and safety of CoronaVac in Turkey and aims to be a pivotal study to support the licensure of this pro
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the resumption of its Early Feasibility Study of the Orion® Visual Cortical Prosthesis System (“Orion”) at UCLA Medical Center (“UCLA”). The study, which includes four participants at UCLA and two participants at Baylor College of Medicine (“
FRISCO, Texas--(BUSINESS WIRE)-- #SOLEOHEALTHMONIQUENELSONWINSGOLDSTEVIEAWARD--Soleo Health’s Monique Nelson Wins Gold Stevie® Award in the 2020 International Business Awards®
BOSTON--(BUSINESS WIRE)--Decibel Therapeutics, a clinical-stage biotechnology company developing novel gene therapeutics for restoration of hearing loss and balance disorders, today announced the appointment of Elisabeth Leiderman, M.D., MBA, as Chief Financial Officer. “Elisabeth brings more than 15 years of business development, strategy and finance experience in the life sciences industry to our team at Decibel. She joins us at an important time as we build Decibel to advance our pipeline of
--(BUSINESS WIRE)--Susan G. Komen: Who: Talbots has created its third “The Art of the Scarf” Collection with three internationally renowned female artists who each were commissioned to design a limited-edition one-of-a-kind silk scarf that tells a story. Full of colorful metaphors and meaning, the scarves evoke emotion with vibrant symbols of courage, strength and determination. The 41” scarves retail for $79.50. In the spirit of women helping women, Talbots will donate 10% of the net proceeds
LONDON--(BUSINESS WIRE)-- #EarSyringeMarket--The Global Ear Syringe Market will grow by USD 9.23 mn during 2020-2024
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has commenced a private offering (the “Offering”), subject to market and other conditions, of $300 million aggregate principal amount of senior secured notes due 2027 (the “notes”). Varex intends to use the net proceeds from the sale of the notes to pay in full all amounts outstanding under its existing credit facility, which includes its term loan and revolving credit facility, and for general corporat
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced the completion of enrollment of its Phase 2a study of FX-322 for sensorineural hearing loss (SNHL). The company anticipates obtaining full results for the study, in which 95 patients were enrolled, in the second quarter of 2021. “We are plea
CARY, N.C.--(BUSINESS WIRE)-- #COVID19Response--Yale New Haven Health and TeleHealth Services developed a community program using cards of support and compassion presented on inpatient televisions.
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite to Participate in Two BioPharma Partnering Conferences
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Medeor announces that the FDA has granted an RMAT designation to MDR-101, designed to enable immune tolerance in kidney transplant patients
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Announces Proposed Private Placement of $500 Million of Convertible Senior Notes
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced that it will present a corporate overview at the Jefferies Next Generation IBD Therapeutics Summit on Wednesday, September 23 at 8:00 a.m. E.T. A webcast of the presentation will be available under the “Investors and Media” section of Seres’ website and will be archived for 21 days. About Seres Therapeutics Seres Therapeutics, Inc., (Nasdaq: MCRB) is a leading microbiome therapeutics platform company deve
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. and Neo Medical SA announce partnership to develop and market single-use, sterile-packaged spinal solutions.
PRINCETON, N.J., & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $BMY #BMS--FDA Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel....
PHOENIX--(BUSINESS WIRE)--Magellan Rx Management has earned NCQA Case Management Accreditation.
CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Anokion Announces Expansion of Exclusive Collaboration with Bristol Myers Squibb to Develop Novel Treatments for Autoimmune Diseases
SAN CARLOS, Calif.--(BUSINESS WIRE)-- #livebiotherapeuticproducts--Siolta Therapeutics raises $30M series B to support clinical development of lead program for the prevention and treatment of allergic diseases.
LONDON--(BUSINESS WIRE)-- #GeneTherapy--Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005, an Investigational Gene Therapy for Dry Age-Related Macular Degeneration.
PALO ALTO, Calif.--(BUSINESS WIRE)-- #biotech--Medable unveils TeleConsent software, making it easy for patients, sites and sponsors to share knowledge and streamline approvals for clinical trials.
MONTREAL & BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD and Knight announces approval of BIJUVA in Canada
NEW YORK--(BUSINESS WIRE)--Columbia Care Announces Illinois Expansion with Opening of Second Dispensary in Villa Park
NEW YORK--(BUSINESS WIRE)---- $BMY--Bristol Myers Squibb Completes Acquisition of Forbius
PLEASANTON, Calif.--(BUSINESS WIRE)-- #cloud--Medis switched to multichannel Veeva CRM in 15 countries across Central and Eastern Europe to advance its commercial strategy.
PLEASANTON, Calif.--(BUSINESS WIRE)-- #cloud--Idorsia selected Veeva Commercial Cloud to enable its digital field force in the U.S., Japan, and countries across Europe.
DUARTE, Calif.--(BUSINESS WIRE)-- #CityofHope--City of Hope licensed intellectual property relating to its chlorotoxin chimeric antigen receptor T cell therapy to Chimeric Therapeutics Limited.
WHIPPANY, N.J.--(BUSINESS WIRE)--A new ad hoc analysis from the Phase III ARAMIS trial showed 97.2% of men with non-metastatic castration-resistant prostate cancer (nmCRPC) taking NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) received the full, planned dose of 600 mg twice daily compared to 98.4% who received ADT alone.1 The percent of planned dose was calculated as the actual dose received (sum of dose received over total time span) over the planned dose per protocol (sum of p
WASHINGTON--(BUSINESS WIRE)--Today the Washington DC-based non-profit the Environmental Investigation Agency (EIA) released recordings of conversations between EIA investigators and executives of Pebble Limited Partnership and Northern Dynasty Minerals (Pebble), the companies behind the contested Pebble Mine project in Alaska. The recordings, which EIA has dubbed “The Pebble Tapes,” reveal Pebble’s plans to build a large and long-lived mine at the headwaters of Bristol Bay in western Alaska. Th
ARLINGTON, Va.--(BUSINESS WIRE)-- #MDIC--The Medical Device Innovation Consortium (MDIC) today announced that its board of directors has elected Jijo James, Chief Medical Officer of Johnson & Johnson Medical Devices Companies, as the new chair-elect of the MDIC board. James has been on the MDIC Board of Directors since 2017 and a member of the MDIC Executive Committee since 2018. He also chairs MDIC’s Clinical Science and Medical Officer forum, a group of senior scientific and medical executives fr
RAMSEY, N.J.--(BUSINESS WIRE)--Pathline Labs has doubled its testing capacity for COVID-19 while maintaining a 24-36-hour turnaround time for processing.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Opdivo Demonstrated Superior Disease-Free Survival in Patients with Resected Esophageal or Gastroesophageal Junction Cancer Compared to Placebo.....
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--KEYTRUDA Plus Chemotherapy Reduced Risk of Death by 27% Vs Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Esophageal Cancer
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Opdivo Plus Chemotherapy Demonstrated Significant Overall and Progression-Free Survival Benefits Versus Chemotherapy in First-Line Treatment....
ROCKVILLE, Md.--(BUSINESS WIRE)--A major objective of a COVID-19 vaccine is to prevent severe disease onset in SARS-CoV-2 infected people. Beth Israel Deaconess Medical Center (BIDMC) immunologist Dan H. Barouch, MD, PhD, and colleagues, including members of the staff at BIOQUAL, showed in recently published previous work that a candidate COVID-19 vaccine raised neutralizing antibodies that robustly protected non-human primates (NHPs) against SARS-CoV-2, the virus that causes COVID-19. In new r
RICHMOND, Calif.--(BUSINESS WIRE)--According to the recent FDA SARS-CoV-2 Reference Panel Comparative Data released on September 15, among all the FDA EUA tests with returned results, DiaCarta’s QuantiVirusTM SARS-CoV-2 Test and QuantiVirusTM SARS-CoV-2 Multiplex Test both rank within the top 3 for product sensitivity. With limit of detection (LoD) at 600 NDU/ml, these tests are 300 to 900-folds better than the least sensitive tests listed (180,000 NDU/ml VTM Swabs and 540,000 NDU/ml Dry Swabs)
LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced that members of the Poxel management and scientific team will participate at upcoming scientific and investor conferences. 56th European Association for the Study of Diabetes (EASD) Annual Meeting Date: September 21-25, 2020 (virtual co
HANGZHOU, China--(BUSINESS WIRE)--Qihan Biotech published research reporting the successful production of its first clinical xenotransplantation prototype.
SACRAMENTO--(BUSINESS WIRE)--Governor Newsom Sign SB 1383 Paid Family Leave Expansion Bill
BOULDER, Colo.--(BUSINESS WIRE)--OnKure and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Combination of OKI-179 and Binimetinib.
LEMONT, Ill.--(BUSINESS WIRE)--Argonne and AT&T announced they’re extending their changing climate analysis from America’s southeastern region to cover the entire contiguous U.S.
WALTHAM, Mass.--(BUSINESS WIRE)-- #EvidenceFirst--Trinity Life Sciences, a leader in global life sciences solutions, introduces Trinity EvidenceFirst™, a high-value subscription service that allows biopharmaceutical companies to take advantage of real-world insights like never before. EvidenceFirst allows organizations to benefit from big, robust data without dealing with the complexities, resource requirements, and costs associated with large data sets. With EvidenceFirst, biopharmaceutical companies can now u
WASHINGTON--(BUSINESS WIRE)--Heart Valve Voice US—a patient-advocacy organization focused on improving the diagnosis, treatment, and management of heart valve disease—is pleased to introduce an intensive, virtual program to train patients and care partners to become research advisors and advocates. The program – Valuing Advocates’ Lives, Voices and Experience (VALVE) in Research – will be the basis for the creation of the heart valve disease research network (HVD Network). This training is bein
LAKELAND, Fla.--(BUSINESS WIRE)--This morning, Publix Pharmacy opened a full-service pharmacy in Halifax Health Medical Center in Daytona Beach, Florida. The pharmacy will provide prescription and over-the-counter medications for patients, visitors and Halifax Health team members. “Publix Pharmacy is excited to begin serving the community at Halifax Health,” Publix Vice President of Pharmacy Dain Rusk said. “Halifax Health’s mission to deliver the best health care possible aligns with our cultu